TD Cowen Maintains Hold on P3 Health Partners, Raises Price Target to $14
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and raises the price target from $3 to $14.
TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and raises the price target from $3 to $14.